Contineum Therapeutics Inc

CTNM

Add to Watchlist

15.490USD

-0.260-1.65%

Close 07-31 16:00（ET）Quotes delayed by 15 min

582.75MMarket Cap

LossP/E TTM

Contineum Therapeutics Inc

15.490

-0.260-1.65%

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Overview

Financials

Discussions

Analysis

Company

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Contineum Therapeutics Inc's Company Valuation

Currency: USD Updated: 2026-07-31

Previous score

7.60

Change

-0.9

The current valuation score of Contineum Therapeutics Inc is 6.70, ranking 265 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -8.01, which is -441.26% below the recent high of 27.33 and -119.86% above the recent low of -17.61.

P/E

Relevant data have not been disclosed by the company yet.

P/B

Relevant data have not been disclosed by the company yet.

P/CF

Relevant data have not been disclosed by the company yet.